![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="2831" height="600"><rect fill-opacity="0"/></svg>)
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="333" height="477"><rect fill-opacity="0"/></svg>)
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="496" height="490"><rect fill-opacity="0"/></svg>)
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="434" height="535"><rect fill-opacity="0"/></svg>)
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="2092" height="1644"><rect fill-opacity="0"/></svg>)
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="1766" height="1736"><rect fill-opacity="0"/></svg>)
It was the launch that sent pharmacy stocks into a tailspin.
Within hours of Amazon announcing it was starting Amazon Pharmacy last November, analysts began issuing warnings to investors in would-be rivals including CVS and Walgreens. “Today’s announcement is a net negative” for drugstores, one note from Evercore analysts read. “Retail Pharmacy is trading down big pre-market,” noted another, from Baird. But nearly a year after Amazon Pharmacy’s public debut — and three years after its purchase of specialty pharmacy startup PillPack — it remains unclear how Amazon will carve out its corner in an increasingly crowded market.
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. First 30 days free.
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
![Erin Brodwin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="80" height="80"><rect fill-opacity="0"/></svg>)
Create a display name to comment
This name will appear with your comment
